The discussion explored several critical areas shaping the future of healthcare on the continent, including the role of alternative reimbursement models in improving access to high-cost biologics for larger patient populations, the potential to significantly reduce HIV through the accelerated rollout of long-acting antiretroviral treatment, and the growing burden of cardiometabolic renal disease as an emerging public health priority that requires earlier screening and intervention.
Stavros also reflected on South Africa’s pharmaceutical localisation roadmap, which now spans four ministries, as well as the importance of African pooled procurement and regulatory harmonisation in supporting the African Union’s target of 60% local procurement.
While Africa continues to face complex healthcare challenges, the interview highlights the significant momentum being built through local manufacturing, strategic partnerships and policy alignment. These efforts present an important opportunity to shape a more self-sufficient and sustainable pharmaceutical ecosystem across the continent.
Read the full conversation here: https://lnkd.in/d388R8Hj.